Effect of regorafenib in delaying definitive deterioration in health-related quality of life in patients with advanced cancer of three different tumor types

The objective of this post hoc exploratory analysis was to explore the impact of regorafenib on delaying HRQOL deterioration across three different tumor types.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Hofheinz, Ralf-Dieter (VerfasserIn) , Bruix, Jordi (VerfasserIn) , Demetri, George D. (VerfasserIn) , Grothey, Axel (VerfasserIn) , Marian, Marisca (VerfasserIn) , Bartsch, Jennifer (VerfasserIn) , Odom, Dawn (VerfasserIn)
Dokumenttyp:	Article (Journal)
Sprache:	Englisch
Veröffentlicht:	12 July 2021
In:	Cancer management and research Year: 2021, Jahrgang: 13, Pages: 5523-5533
ISSN:	1179-1322
DOI:	10.2147/CMAR.S305939
Online-Zugang:	Verlag, Volltext: https://doi.org/10.2147/CMAR.S305939 Verlag: https://www.dovepress.com/effect-of-regorafenib-in-delaying-definitive-deterioration-in-health-r-peer-reviewed-fulltext-article-CMAR
Verfasserangaben:	Ralf-Dieter Hofheinz, Jordi Bruix, George D. Demetri, Axel Grothey, Marisca Marian, Jennifer Bartsch, Dawn Odom

Beschreibung
Zusammenfassung:	The objective of this post hoc exploratory analysis was to explore the impact of regorafenib on delaying HRQOL deterioration across three different tumor types.
Beschreibung:	Gesehen am 17.01.2023
Beschreibung:	Online Resource
ISSN:	1179-1322
DOI:	10.2147/CMAR.S305939